➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
McKesson
Moodys
Dow
McKinsey

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Fluphenazine hydrochloride - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for fluphenazine hydrochloride and what is the scope of patent protection?

Fluphenazine hydrochloride is the generic ingredient in three branded drugs marketed by Ani Pharms Inc, Pharm Assoc, Schering, Apothecon, Fresenius Kabi Usa, Lannett Co Inc, Mylan, Sandoz, and Watson Labs, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for fluphenazine hydrochloride. Eight suppliers are listed for this compound.

Recent Clinical Trials for fluphenazine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Drug Safety and Effectiveness Network, CanadaN/A
Canadian Network for Observational Drug Effect Studies, CNODESN/A
Canadian Institutes of Health Research (CIHR)N/A

See all fluphenazine hydrochloride clinical trials

Pharmacology for fluphenazine hydrochloride
Drug ClassPhenothiazine

US Patents and Regulatory Information for fluphenazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Co Inc FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 089743-001 Aug 25, 1988 AB RX No Yes   Start Trial   Start Trial   Start Trial
Watson Labs FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 088544-001 Dec 18, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 089586-001 Oct 16, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Schering PERMITIL fluphenazine hydrochloride TABLET;ORAL 012034-006 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 089586-003 Oct 16, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
McKesson
Moodys
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.